nodes	percent_of_prediction	percent_of_DWPC	metapath
Cocaine—SLC6A3—Gilles de la Tourette syndrome	0.933	1	CbGaD
Cocaine—Ioflupane I 123—SLC6A3—Gilles de la Tourette syndrome	0.0106	1	CrCbGaD
Cocaine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.0072	0.169	CbGeAlD
Cocaine—SCN11A—nervous system—Gilles de la Tourette syndrome	0.00289	0.0679	CbGeAlD
Cocaine—SCN11A—central nervous system—Gilles de la Tourette syndrome	0.00278	0.0653	CbGeAlD
Cocaine—SCN11A—brain—Gilles de la Tourette syndrome	0.00221	0.0519	CbGeAlD
Cocaine—SCN10A—nervous system—Gilles de la Tourette syndrome	0.00146	0.0344	CbGeAlD
Cocaine—SCN10A—central nervous system—Gilles de la Tourette syndrome	0.00141	0.0331	CbGeAlD
Cocaine—SLC6A3—midbrain—Gilles de la Tourette syndrome	0.00137	0.0323	CbGeAlD
Cocaine—SCN5A—nervous system—Gilles de la Tourette syndrome	0.00133	0.0313	CbGeAlD
Cocaine—SCN5A—central nervous system—Gilles de la Tourette syndrome	0.00128	0.0301	CbGeAlD
Cocaine—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.00126	0.0296	CbGeAlD
Cocaine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.00113	0.0266	CbGeAlD
Cocaine—SLC6A3—nervous system—Gilles de la Tourette syndrome	0.00113	0.0265	CbGeAlD
Cocaine—SCN10A—brain—Gilles de la Tourette syndrome	0.00112	0.0263	CbGeAlD
Cocaine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00109	0.0256	CbGeAlD
Cocaine—SLC6A3—central nervous system—Gilles de la Tourette syndrome	0.00109	0.0256	CbGeAlD
Cocaine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00108	0.0788	CbGpPWpGaD
Cocaine—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.00104	0.0243	CbGeAlD
Cocaine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00103	0.0242	CbGeAlD
Cocaine—SCN5A—brain—Gilles de la Tourette syndrome	0.00102	0.0239	CbGeAlD
Cocaine—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000997	0.0234	CbGeAlD
Cocaine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000993	0.0233	CbGeAlD
Cocaine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.000911	0.0214	CbGeAlD
Cocaine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000877	0.0206	CbGeAlD
Cocaine—CHRM2—brain—Gilles de la Tourette syndrome	0.000866	0.0203	CbGeAlD
Cocaine—SLC6A3—brain—Gilles de la Tourette syndrome	0.000863	0.0203	CbGeAlD
Cocaine—SLC6A4—brain—Gilles de la Tourette syndrome	0.000791	0.0186	CbGeAlD
Cocaine—CHRM1—brain—Gilles de la Tourette syndrome	0.000788	0.0185	CbGeAlD
Cocaine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000697	0.0164	CbGeAlD
Cocaine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.000673	0.0489	CbGpPWpGaD
Cocaine—CYP2C8—brain—Gilles de la Tourette syndrome	0.000572	0.0134	CbGeAlD
Cocaine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.000542	0.0395	CbGpPWpGaD
Cocaine—SLC6A4—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.000516	0.0375	CbGpPWpGaD
Cocaine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000507	0.0119	CbGeAlD
Cocaine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000499	0.0117	CbGeAlD
Cocaine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000488	0.0115	CbGeAlD
Cocaine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00048	0.0113	CbGeAlD
Cocaine—SLC6A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.000467	0.034	CbGpPWpGaD
Cocaine—SLC6A2—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.000443	0.0323	CbGpPWpGaD
Cocaine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.000384	0.0279	CbGpPWpGaD
Cocaine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000381	0.00896	CbGeAlD
Cocaine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.000379	0.0276	CbGpPWpGaD
Cocaine—SLC22A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.000376	0.0274	CbGpPWpGaD
Cocaine—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000327	0.0238	CbGpPWpGaD
Cocaine—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000323	0.0235	CbGpPWpGaD
Cocaine—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000318	0.0231	CbGpPWpGaD
Cocaine—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000314	0.0228	CbGpPWpGaD
Cocaine—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000296	0.0215	CbGpPWpGaD
Cocaine—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000292	0.0213	CbGpPWpGaD
Cocaine—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000275	0.02	CbGpPWpGaD
Cocaine—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000272	0.0198	CbGpPWpGaD
Cocaine—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000267	0.0194	CbGpPWpGaD
Cocaine—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000264	0.0192	CbGpPWpGaD
Cocaine—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000249	0.0181	CbGpPWpGaD
Cocaine—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000246	0.0179	CbGpPWpGaD
Cocaine—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000207	0.0151	CbGpPWpGaD
Cocaine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000205	0.0149	CbGpPWpGaD
Cocaine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.000183	0.0133	CbGpPWpGaD
Cocaine—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000174	0.0127	CbGpPWpGaD
Cocaine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000172	0.0125	CbGpPWpGaD
Cocaine—SLC6A4—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000153	0.0111	CbGpPWpGaD
Cocaine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.000147	0.0107	CbGpPWpGaD
Cocaine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000144	0.0104	CbGpPWpGaD
Cocaine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000139	0.0101	CbGpPWpGaD
Cocaine—SLC6A2—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000132	0.00958	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000129	0.00937	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000125	0.0091	CbGpPWpGaD
Cocaine—SCN11A—Axon guidance—MET—Gilles de la Tourette syndrome	0.000123	0.00898	CbGpPWpGaD
Cocaine—SLC6A4—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000116	0.00848	CbGpPWpGaD
Cocaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000115	0.00833	CbGpPWpGaD
Cocaine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	9.99e-05	0.00727	CbGpPWpGaD
Cocaine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	9.09e-05	0.00661	CbGpPWpGaD
Cocaine—SCN11A—Developmental Biology—MET—Gilles de la Tourette syndrome	8.81e-05	0.00641	CbGpPWpGaD
Cocaine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	8.3e-05	0.00604	CbGpPWpGaD
Cocaine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	8.25e-05	0.006	CbGpPWpGaD
Cocaine—SCN10A—Axon guidance—MET—Gilles de la Tourette syndrome	8.09e-05	0.00589	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	7.71e-05	0.00561	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	7.49e-05	0.00545	CbGpPWpGaD
Cocaine—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	6.97e-05	0.00507	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	6.72e-05	0.00489	CbGpPWpGaD
Cocaine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	6.69e-05	0.00487	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	6.52e-05	0.00474	CbGpPWpGaD
Cocaine—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	6.32e-05	0.0046	CbGpPWpGaD
Cocaine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	6.32e-05	0.00459	CbGpPWpGaD
Cocaine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	6.23e-05	0.00454	CbGpPWpGaD
Cocaine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	6.13e-05	0.00446	CbGpPWpGaD
Cocaine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	6.08e-05	0.00442	CbGpPWpGaD
Cocaine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	6.05e-05	0.0044	CbGpPWpGaD
Cocaine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	5.91e-05	0.0043	CbGpPWpGaD
Cocaine—SCN10A—Developmental Biology—MET—Gilles de la Tourette syndrome	5.77e-05	0.0042	CbGpPWpGaD
Cocaine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	5.71e-05	0.00416	CbGpPWpGaD
Cocaine—SCN5A—Axon guidance—MET—Gilles de la Tourette syndrome	5.69e-05	0.00414	CbGpPWpGaD
Cocaine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	5.64e-05	0.0041	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	5.41e-05	0.00394	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	5.34e-05	0.00389	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	5.25e-05	0.00382	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	5.19e-05	0.00377	CbGpPWpGaD
Cocaine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	5.18e-05	0.00377	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	4.89e-05	0.00356	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	4.83e-05	0.00351	CbGpPWpGaD
Cocaine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	4.63e-05	0.00337	CbGpPWpGaD
Cocaine—CYP3A7—Metabolism—HDC—Gilles de la Tourette syndrome	4.58e-05	0.00333	CbGpPWpGaD
Cocaine—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	4.57e-05	0.00333	CbGpPWpGaD
Cocaine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	4.22e-05	0.00307	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	4.12e-05	0.003	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	4.07e-05	0.00296	CbGpPWpGaD
Cocaine—SCN5A—Developmental Biology—MET—Gilles de la Tourette syndrome	4.06e-05	0.00295	CbGpPWpGaD
Cocaine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4e-05	0.00291	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4e-05	0.00291	CbGpPWpGaD
Cocaine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	3.95e-05	0.00287	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	3.95e-05	0.00287	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	3.73e-05	0.00271	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	3.68e-05	0.00268	CbGpPWpGaD
Cocaine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	3.43e-05	0.00249	CbGpPWpGaD
Cocaine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	3.4e-05	0.00247	CbGpPWpGaD
Cocaine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	3.38e-05	0.00246	CbGpPWpGaD
Cocaine—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	3.31e-05	0.00241	CbGpPWpGaD
Cocaine—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	2.87e-05	0.00209	CbGpPWpGaD
Cocaine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.61e-05	0.0019	CbGpPWpGaD
Cocaine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	2.58e-05	0.00187	CbGpPWpGaD
Cocaine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	2.35e-05	0.00171	CbGpPWpGaD
Cocaine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	2.33e-05	0.0017	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.33e-05	0.00169	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.3e-05	0.00167	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.26e-05	0.00164	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.23e-05	0.00162	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.11e-05	0.00154	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.11e-05	0.00153	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.09e-05	0.00152	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.08e-05	0.00151	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.05e-05	0.00149	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.03e-05	0.00147	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.91e-05	0.00139	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	1.89e-05	0.00137	CbGpPWpGaD
Cocaine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	1.54e-05	0.00112	CbGpPWpGaD
Cocaine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.47e-05	0.00107	CbGpPWpGaD
Cocaine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.46e-05	0.00106	CbGpPWpGaD
Cocaine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.34e-05	0.000974	CbGpPWpGaD
Cocaine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.32e-05	0.000962	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.25e-05	0.000909	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.23e-05	0.000897	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.21e-05	0.000882	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.2e-05	0.000871	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.13e-05	0.000822	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.12e-05	0.000811	CbGpPWpGaD
Cocaine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.91e-06	0.000576	CbGpPWpGaD
Cocaine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.81e-06	0.000568	CbGpPWpGaD
